Malignant Pericardial Effusion in Ovarian Malignancy: A Treatable Oncologic Emergency

Tamar Perri; Daniel Lantsberg; Gilad Ben-Baruch; Mario E. Beiner; Ariella Jakobson-Setton; Jacob Korach

doi:10.1016/j.jemermed.2015.04.024

Malignant Pericardial Effusion in Ovarian Malignancy: A Treatable Oncologic Emergency

Tamar Perri^*, Daniel Lantsberg, Gilad Ben-Baruch, Mario E. Beiner, Ariella Jakobson-Setton, Jacob Korach

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Background Pericardial tamponade is a life-threatening condition that can occur, albeit rarely, in patients with ovarian cancer. Whether or not prolonged survival is possible after such an event is debatable. Our aim was to describe our experience with seven ovarian cancer patients who experienced malignant cardiac tamponade at tumor diagnosis or at recurrence. Case Report Six patients were treated with pericardiocentesis and one with pericardial fenestration. Survival after tamponade ranged from 3 to 72 weeks. Why Should an Emergency Physician Be Aware of This? We suggest that when pericardial effusion occurs in patients with recurrent ovarian cancer, timely diagnosis and proper management might allow palliation and prolongation of life.

Original language	English
Pages (from-to)	281-283
Number of pages	3
Journal	Journal of Emergency Medicine
Volume	49
Issue number	3
DOIs	https://doi.org/10.1016/j.jemermed.2015.04.024
State	Published - 24 Mar 2015

Keywords

cardiac tamponade
malignant pericardial effusion
ovarian cancer

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jemermed.2015.04.024

Cite this

@article{c760032746f4480ca185e7402bf01126,

title = "Malignant Pericardial Effusion in Ovarian Malignancy: A Treatable Oncologic Emergency",

abstract = "Background Pericardial tamponade is a life-threatening condition that can occur, albeit rarely, in patients with ovarian cancer. Whether or not prolonged survival is possible after such an event is debatable. Our aim was to describe our experience with seven ovarian cancer patients who experienced malignant cardiac tamponade at tumor diagnosis or at recurrence. Case Report Six patients were treated with pericardiocentesis and one with pericardial fenestration. Survival after tamponade ranged from 3 to 72 weeks. Why Should an Emergency Physician Be Aware of This? We suggest that when pericardial effusion occurs in patients with recurrent ovarian cancer, timely diagnosis and proper management might allow palliation and prolongation of life.",

keywords = "cardiac tamponade, malignant pericardial effusion, ovarian cancer",

author = "Tamar Perri and Daniel Lantsberg and Gilad Ben-Baruch and Beiner, {Mario E.} and Ariella Jakobson-Setton and Jacob Korach",

note = "Publisher Copyright: {\textcopyright} 2015 Elsevier Inc.",

year = "2015",

month = mar,

day = "24",

doi = "10.1016/j.jemermed.2015.04.024",

language = "אנגלית",

volume = "49",

pages = "281--283",

journal = "Journal of Emergency Medicine",

issn = "0736-4679",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Malignant Pericardial Effusion in Ovarian Malignancy

T2 - A Treatable Oncologic Emergency

AU - Perri, Tamar

AU - Lantsberg, Daniel

AU - Ben-Baruch, Gilad

AU - Beiner, Mario E.

AU - Jakobson-Setton, Ariella

AU - Korach, Jacob

PY - 2015/3/24

Y1 - 2015/3/24

N2 - Background Pericardial tamponade is a life-threatening condition that can occur, albeit rarely, in patients with ovarian cancer. Whether or not prolonged survival is possible after such an event is debatable. Our aim was to describe our experience with seven ovarian cancer patients who experienced malignant cardiac tamponade at tumor diagnosis or at recurrence. Case Report Six patients were treated with pericardiocentesis and one with pericardial fenestration. Survival after tamponade ranged from 3 to 72 weeks. Why Should an Emergency Physician Be Aware of This? We suggest that when pericardial effusion occurs in patients with recurrent ovarian cancer, timely diagnosis and proper management might allow palliation and prolongation of life.

AB - Background Pericardial tamponade is a life-threatening condition that can occur, albeit rarely, in patients with ovarian cancer. Whether or not prolonged survival is possible after such an event is debatable. Our aim was to describe our experience with seven ovarian cancer patients who experienced malignant cardiac tamponade at tumor diagnosis or at recurrence. Case Report Six patients were treated with pericardiocentesis and one with pericardial fenestration. Survival after tamponade ranged from 3 to 72 weeks. Why Should an Emergency Physician Be Aware of This? We suggest that when pericardial effusion occurs in patients with recurrent ovarian cancer, timely diagnosis and proper management might allow palliation and prolongation of life.

KW - cardiac tamponade

KW - malignant pericardial effusion

KW - ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=84955200738&partnerID=8YFLogxK

U2 - 10.1016/j.jemermed.2015.04.024

DO - 10.1016/j.jemermed.2015.04.024

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:84955200738

SN - 0736-4679

VL - 49

SP - 281

EP - 283

JO - Journal of Emergency Medicine

JF - Journal of Emergency Medicine

IS - 3

ER -

Malignant Pericardial Effusion in Ovarian Malignancy: A Treatable Oncologic Emergency

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this